PTPN1 and type 2 diabetes mellitus: Dimer structures of nature-mimicking hydroxybenzofuran methyl ketones have been evaluated for antidiabetic activity through inhibition of protein tyrosine phosphatase-1B (PTP-1B), which is a legitimate target for the treatment of Type 2 diabetes (Fig. 1 compound D)30.